Mikhail Blagosklonny devotion to Acquiring an Effective Cancer Treatment

Posted on July 7, 2017

Mikhail Blagosklonny is an oncology professor at the Roswell Park Cancer Institution. He is a scientist and specializes in cancer and aging. He has an M.D. in internal medicine from the First Pavlov State Medical University, St. Petersburg. He advanced his education in the same university and attained a PhD in experimental medicine and cardiology.In 2002, Mikhail was appointed as the associate professor of medicine at the New York Medical College situated in Valhalla, New York. He was hired by the Ordway Research Institute in Albany, New York, as a senior scientist. In 2009, Mikhail became a professor of oncology at the renowned Roswell Park Cancer Institute. He had gained vast knowledge and experience in his previous workplaces, and this made him an excellent professor. Mikhail based his research on biogerontology (the underlying mechanism of aging), cancer, anti-aging drugs, as well as cancer therapies which guard the healthy body cells against destruction.

Mikhail also serves as the editor-in-chief of Oncotarget, and Aging. He is not only the founder editor of Cell Cycle but also the editor-in-chief. He is an associate editor of cancer therapy and biology. Mikhail is on the editorial panel of Cell Death and Differentiation. He released a proposition concerning the potential role of TOR signalling in cancer and aging. In the hypothesis, Mikhail proposed the utilization of Rapamycin as a possible treatment for life extension.Mikhail gives insight into how rejuvenation of cells helps to reduce the incidences of cancer in aged people. Mikhail defines aging as the progressive growth of cells. Rapamycin is a drug used to treat cancer. Mikhail is one of the enthusiastic advocates for Rapamycin in the longevity research. Mikhail argues that the usage of Rapamycin can minimize the aging process in human beings as it strengthens the body’s immunity. Over the years, scientists have provided several results on the use of anti-aging products in cancer management.

Most of Mikhail studies range from clinical investigations to molecular and cellular biology. The studies include ontogenesis, apoptosis, anti-cancer therapeutics, signal transduction, tumor suppressors, cell cycle, mitosis, and drug resistance for normal body cells. Mikhail writes about aging hyperfunction theory, chemotherapeutic, and cyclotherapy engineering. He has published more than 300 book chapters, research articles and reviews. Mikhail Blagosklonny has used approximately 25,000 citations, therefore, has an h-index of 83. Also, he is an associate editor of the American Journal of Pathology, PLOS ONE, and the International Journal of Cancer.Mikhail Blagosklonny is famous for his passion in oncology. He firmly believes that controlling aging and cancer is achievable. According to Mikhail, cancer can be cured, which is why he recommends the use of Rapamycin. Mikhail’s devotion to his work has brought great achievements in his field of specialization. He is one of the greatest oncologist researchers in the world today. His achievements are attributed to his love for humanity and his vision for a disease free society.It is clear that Mikhail is an accomplished Scientist, professor of oncology and medicine, and physician. He has risen through ranks and holds several top-notch appointments.

Categories: Cancer Treatment, Entrepreneur


Comments are closed